help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petersen, K. F.
Right arrow Articles by Bergeron, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersen, K. F.
Right arrow Articles by Bergeron, R.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 9 4656-4664
Copyright © 2004 by The Endocrine Society

Regulation of Net Hepatic Glycogenolysis and Gluconeogenesis during Exercise: Impact of Type 1 Diabetes

Kitt Falk Petersen, Thomas B. Price and Raynald Bergeron

Departments of Internal Medicine (K.F.P., R.B.) and Diagnostic Radiology (T.B.P.), Yale University School of Medicine, New Haven, Connecticut 06520-8020

Address all correspondence and requests for reprints to: Dr. Kitt Falk Petersen, Department of Internal Medicine, Yale University School of Medicine, 300 Cedar Street, S263, P.O. Box 208020, New Haven, Connecticut 06520-8020.

The effects of type 1 diabetes on the contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production (GP) at rest and during moderate (MOD) and high (HI) intensity running were examined in healthy control (n = 6) and type 1 diabetic (n = 5) subjects matched for age, weight, and maximum aerobic capacity by combined noninvasive measurements of hepatic glycogen content using 13C nuclear magnetic resonance spectroscopy and determination of GP using [6,6-2H2]glucose. In the control subjects, GP increased in proportion to the intensity of the exercise [at rest (REST), 14.3 ± 0.5; MOD, 18.1 ± 0.9; HI, 28.8 ± 1.3 µmol/(kg-min); P = 0.001, three-way comparison], and this was accounted for by an increase in the percent contribution of net hepatic glycogenolysis to GP (REST, 32 ± 1%; MOD, 49 ± 5%; HI, 57 ± 5%; P = 0.006). In the diabetic subjects, resting rates of GP were 60% higher than those in the control subjects (P < 0.0001) and increased in proportion to the workload. In contrast, the contributions of net hepatic glycogenolysis to GP were consistently lower than those in the control subjects (REST, 20 ± 6%; MOD, 32 ± 13%; HI, 32 ± 3%; P = 0.006 vs. control), and the exaggerated rates of GP could be entirely accounted for by increased rates of gluconeogenesis. In conclusion, 1) increases in GP in healthy control subjects with exercise intensity can be entirely attributed to increases in net hepatic glycogenolysis. 2) In contrast, moderately controlled type 1 diabetic subjects exhibit increased rates of GP both at rest and during exercise, which can be entirely accounted for by increased gluconeogenesis.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Dufour, V. Lebon, G. I. Shulman, and K. F. Petersen
Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans
Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E231 - E235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. J. Stevenson, P. E. Thelwall, K. Thomas, F. Smith, J. Brand-Miller, and M. I. Trenell
Dietary glycemic index influences lipid oxidation but not muscle or liver glycogen oxidation during exercise
Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1140 - E1147.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Wende, P. J. Schaeffer, G. J. Parker, C. Zechner, D.-H. Han, M. M. Chen, C. R. Hancock, J. J. Lehman, J. M. Huss, D. A. McClain, et al.
A Role for the Transcriptional Coactivator PGC-1{alpha} in Muscle Refueling
J. Biol. Chem., December 14, 2007; 282(50): 36642 - 36651.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. K. McMahon, L. D. Ferreira, N. Ratnam, R. J. Davey, L. M. Youngs, E. A. Davis, P. A. Fournier, and T. W. Jones
Glucose Requirements to Maintain Euglycemia after Moderate-Intensity Afternoon Exercise in Adolescents with Type 1 Diabetes Are Increased in a Biphasic Manner
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 963 - 968.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. G. Jones, A. Fagulha, C. Barosa, M. Bastos, L. Barros, C. Baptista, M. M. Caldeira, and M. Carvalheiro
Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen.
Diabetes, August 1, 2006; 55(8): 2294 - 2300.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Kishore, I. Gabriely, M.-H. Cui, J. Di Vito, S. Gajavelli, J.-H. Hwang, and H. Shamoon
Role of Hepatic Glycogen Breakdown in Defective Counterregulation of Hypoglycemia in Intensively Treated Type 1 Diabetes
Diabetes, March 1, 2006; 55(3): 659 - 666.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society